These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9579828)
1. Transfection of COS-1 cells with DT-diaphorase cDNA: role of a base change at position 609. Misra V; Klamut HJ; Rauth AM Br J Cancer; 1998 Apr; 77(8):1236-40. PubMed ID: 9579828 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity. Misra V; Grondin A; Klamut HJ; Rauth AM Br J Cancer; 2000 Oct; 83(8):998-1002. PubMed ID: 10993645 [TBL] [Abstract][Full Text] [Related]
3. Factors influencing the induction of DT-diaphorase activity by 1,2-dithiole-3-thione in human tumor cell lines. Begleiterabc A; Leith MK; Doherty GP; Digbya TJ; Pan S Biochem Pharmacol; 2001 Apr; 61(8):955-64. PubMed ID: 11286987 [TBL] [Abstract][Full Text] [Related]
4. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues. Gasdaska PY; Fisher H; Powis G Cancer Res; 1995 Jun; 55(12):2542-7. PubMed ID: 7780966 [TBL] [Abstract][Full Text] [Related]
5. Demonstration of the activation of prodrug CB 1954 using human DT-diaphorase mutant Q104Y-transfected MDA-MB-231 cells and mouse xenograft model. Wu K; Eng E; Knox R; Chen S Arch Biochem Biophys; 2001 Jan; 385(1):203-8. PubMed ID: 11361019 [TBL] [Abstract][Full Text] [Related]
6. Involvement of activator protein-1 and nuclear factor-kappaB transcription factors in the control of the DT-diaphorase expression induced by mitomycin C treatment. Yao KS; Hageboutros A; Ford P; O'Dwyer PJ Mol Pharmacol; 1997 Mar; 51(3):422-30. PubMed ID: 9058597 [TBL] [Abstract][Full Text] [Related]
7. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Traver RD; Siegel D; Beall HD; Phillips RM; Gibson NW; Franklin WA; Ross D Br J Cancer; 1997; 75(1):69-75. PubMed ID: 9000600 [TBL] [Abstract][Full Text] [Related]
9. Gene targeting of DT-diaphorase in mouse embryonic stem cells: establishment of null mutant and its mitomycin C-resistance. Yoshida T; Tsuda H Biochem Biophys Res Commun; 1995 Sep; 214(2):701-8. PubMed ID: 7677784 [TBL] [Abstract][Full Text] [Related]
10. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Kuehl BL; Paterson JW; Peacock JW; Paterson MC; Rauth AM Br J Cancer; 1995 Sep; 72(3):555-61. PubMed ID: 7669561 [TBL] [Abstract][Full Text] [Related]
11. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Joseph P; Jaiswal AK Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8413-7. PubMed ID: 8078896 [TBL] [Abstract][Full Text] [Related]
12. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase. Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423 [TBL] [Abstract][Full Text] [Related]
13. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase. Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528 [TBL] [Abstract][Full Text] [Related]
14. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones. Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816 [TBL] [Abstract][Full Text] [Related]
15. DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis. Rauth AM; Goldberg Z; Misra V Oncol Res; 1997; 9(6-7):339-49. PubMed ID: 9406240 [TBL] [Abstract][Full Text] [Related]
16. Increased NAD(P)H:(quinone-acceptor)oxidoreductase activity is associated with density-dependent growth inhibition of normal but not transformed cells. Schlager JJ; Hoerl BJ; Riebow J; Scott DP; Gasdaska P; Scott RE; Powis G Cancer Res; 1993 Mar; 53(6):1338-42. PubMed ID: 8443814 [TBL] [Abstract][Full Text] [Related]
17. Over-expression of DT-diaphorase in transfected NIH 3T3 cells does not lead to increased anticancer quinone drug sensitivity: a questionable role for the enzyme as a target for bioreductively activated anticancer drugs. Powis G; Gasdaska PY; Gallegos A; Sherrill K; Goodman D Anticancer Res; 1995; 15(4):1141-5. PubMed ID: 7653992 [TBL] [Abstract][Full Text] [Related]
18. Implication of alternative splicing for expression of a variant NAD(P)H:quinone oxidoreductase-1 with a single nucleotide polymorphism at 465C>T. Pan SS; Han Y; Farabaugh P; Xia H Pharmacogenetics; 2002 Aug; 12(6):479-88. PubMed ID: 12172217 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity. Muñoz P; Paris I; Sanders LH; Greenamyre JT; Segura-Aguilar J Biochim Biophys Acta; 2012 Jul; 1822(7):1125-36. PubMed ID: 22483869 [TBL] [Abstract][Full Text] [Related]
20. Roles of DT diaphorase in the genotoxicity of nitroaromatic compounds in human and fish cell lines. Hasspieler BM; Haffner GD; Adeli K J Toxicol Environ Health; 1997 Oct; 52(2):137-48. PubMed ID: 9310146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]